Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-13
2005-09-13
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S300000, C514S338000, C546S113000, C546S197000, C546S277400
Reexamination Certificate
active
06943178
ABSTRACT:
Compounds of the formulauseful for the treatment of diseases such as depression (including but not limited to major depressive disorder, childhood depression and dysthymia), anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder attention deficit disorder (with and without hyperactivity), obsessive compulsive disorder (including trichotillomania), social anxiety disorder, generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa, bulimia nervosa, vasomotor flushing, cocaine and alcohol addiction, sexual dysfunction and related illnesses.
REFERENCES:
patent: 5276042 (1994-01-01), Crenshaw et al.
patent: 5318988 (1994-06-01), Schohe-Loop et al.
patent: 5371094 (1994-12-01), Heine et al.
patent: 5741789 (1998-04-01), Hibschman et al.
patent: 5811436 (1998-09-01), Leonard et al.
patent: 5824682 (1998-10-01), Van Lommen et al.
patent: 5869490 (1999-02-01), Stack
patent: 6458802 (2002-10-01), Tran et al.
patent: 6555560 (2003-04-01), Tran et al.
patent: 6599915 (2003-07-01), Tran et al.
patent: 0 771 800 (1997-05-01), None
patent: 0 963 983 (1999-05-01), None
patent: WO 91/13872 (1991-09-01), None
patent: WO 92/09281 (1992-06-01), None
Lesch et al. “Long term fluoxetine treatment . . . ” CA 115:248044 (1991).
Leonard “Pharmacological differences of serotonin . . . ” CA 117:123896 (1992).
Greenblatt et al. “Inhibition of human cytochrome . . . ” CA 125:315899 (1996).
Gil et al. “Extrapyramidal symptomes . . . ” CA 127:341255 (1997).
Gray et al. “Do alpha2-adrenoceptors . . . ” CA 131:266945 (1999).
Hidalgo et al. “Selective serotonin reuptake . . . ” CA 132:273684 (2000).
Goeringer et al. “Postmortem forensic . . . ” CA 133:160613 (2000).
Asakura et al. “Influences of chronic stress . . . ” CA 134:157659 (2001).
Stack Gary P.
Tran Megan
Chang Celia
Woodcock & Washburn LLP
Wyeth
LandOfFree
Antidepressant azaheterocyclylmethyl derivatives of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antidepressant azaheterocyclylmethyl derivatives of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidepressant azaheterocyclylmethyl derivatives of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3416934